Antithrombotic compound

Details for Australian Patent Application No. 2005223339 (hide)

Owner sanofi-aventis

Inventors De Kort, Martin; Buijsman, Rogier Christian; Meuleman, Dirk Gerrit; Van Boeckel, Constant

Agent Davies Collison Cave

Pub. Number AU-B-2005223339

PCT Pub. Number WO2005/090382

Priority 04005343.1 05.03.04 EP

Filing date 3 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 23 June 2011

International Classifications

C07H 11/00 (2006.01) Compounds containing saccharide radicals esterified by inorganic acids

C07H 15/04 (2006.01) Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

C07H 15/08 (2006.01) Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

C07K 5/00 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/072 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 9/00 (2006.01) Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/090382 Priority application(s): WO2005/090382

23 June 2011 Application Accepted

  Published as AU-B-2005223339

20 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005223347-Method for enriching trehalose with the aid of alumosilicates

2005223338-Synthesis of 2-methyl-4-(4-methyl-1-piperazinyl)-10h -thieno[2, 3-b][1,5]benzodiazepine and salts thereof